Abiopharma

🔍 LeBuhn Richard T. (Director)

Company: STAAR SURGICAL CO (STAA)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 7,524 shares of OPTION TO PURCHASE COMMON STOCK at $18.46 per share (Derivative)
  Date: 2026-03-06 | Code: A | Expires: 2036-03-05 | equity_swap_involved: 0 | shares_owned_after: 7,524.00 | transaction_form_type: 4 | Footnotes: F2, F1

Footnotes:

• F1: These options will vest and become exercisable on the earlier of: (a) June 18, 2026 and (b) the date of STAAR Surgical Company's (the "Issuer") 2026 annual meeting of shareholders, subject, in each case, to Richard T. LeBuhn's (the "Reporting Person") continuous service with the Issuer.
• F2: These options were granted to the Reporting Person by the Issuer on March 6, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.